Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 10/20 | 0.79 |
| ▸ | ITGA2B | P08514 | 10/20 | 0.79 |
| ▸ | LSS | P48449 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6180151 | 0.83 | ITGB3 (0.61) | ITGB3ITGA2B | |
| SCHEMBL7782706 | 0.82 | ITGB3 (0.59) | ITGB3ITGA2BKMT2AMEN1LMNA | |
| SCHEMBL7788456 | 0.82 | ITGB3 (0.61) | ITGB3ITGA2BLSSTDP1KMT2A | |
| Hydrochloric Acid SCHEMBL7402499 | 0.82 | ITGB3 (0.60) | ITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL8838028 | 0.82 | ITGB3 (0.60) | ITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL9024492 | 0.81 | ITGB3 (0.58) | ITGB3ITGA2BLSSTDP1KMT2A | |
| SCHEMBL26706322 | 0.81 | ALDH1A1 (0.59) | ITGB3ITGA2BLSSTDP1KMT2A | |
| SCHEMBL7790309 | 0.81 | ITGB3 (0.57) | ITGB3ITGA2BKMT2AMEN1LMNA | |
| Hydrochloric Acid SCHEMBL9023673 | 0.80 | ITGB3 (0.60) | ITGB3ITGA2BLSSTDP1KMT2A | |
| SCHEMBL7788302 | 0.79 | ITGB3 (0.67) | ITGB3ITGA2BLSSTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010009912-A1 | NEW DERIVATIVES OF PYRIDIL PIPERAZINE OR PYRIDAZINYL PIPERAZYL, PROCESS FOR PRODUCTION THEREOF AND MEDICAMENTS CONTAINING THESE COMPOUNDS | TSAKLAKIDIS CHRISTOS (DE) | 2001-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010009912-A1 | NEW DERIVATIVES OF PYRIDIL PIPERAZINE OR PYRIDAZINYL PIPERAZYL, PROCESS FOR PRODUCTION THEREOF AND MEDICAMENTS CONTAINING THESE COMPOUNDS | CYP4B1, NR4A1, CYP3A43 | ITGB3 1193/4885ITGA2B 3222/4885LSS 2870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.